MP4 September 6, 2017 6:05 pm Boston Business Journal Report: Verastem Eyes FDA Filing Biotech reporter Max Stendahl joins necn to discuss his story, “Needham’s Verastem eyes FDA filing after lead drug passes late-stage trial.” US & World Videos 1:32 Amber Alert for 2 NH girls canceled, father in custody 2:53 Latest on Lewiston, Maine shootings 2:01 Local researchers looking to turn plastic into fuel 1:45 Gov. Healey to sign bottle ban order for state agencies 2:41 Leominster students return to school after floods
